Solid Biosciences (SLDB) PT Raised to $26 at Cantor Fitzgerald Before INSPIRE Ph1/2 Readout
Tweet Send to a Friend
Cantor Fitzgerald analyst Kristen Kluska raised the price target on Solid Biosciences (NASDAQ: SLDB) to $26.00 (from $16.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
